A Case of Ovarian Steroid Cell Tumor, Not Otherwise Specified, Treated with Surgery and Gonadotropin Releasing Hormone Agonist.
- Author:
Dong Hae CHUNG
1
;
Seung Ho LEE
;
Kwang Beom LEE
Author Information
- Publication Type:Case Report
- Keywords: Gonadotropins; Ovarian neoplasms; Ovary; Sex cord-gonadal stromal tumors; Steroids
- MeSH: Adult; Female; Gonadotropin-Releasing Hormone*; Gonadotropins; Hair; Humans; Laparoscopy; Leydig Cell Tumor; Luteoma; Metrorrhagia; Neoplasm Metastasis; Ovarian Neoplasms; Ovariectomy; Ovary; Physical Examination; Recurrence; Sex Cord-Gonadal Stromal Tumors; Steroids; Ultrasonography
- From:Journal of Menopausal Medicine 2014;20(1):39-42
- CountryRepublic of Korea
- Language:English
- Abstract: Steroid cell tumors account for less than 0.1% of all ovarian tumors. There are three steroid cell tumor subtypes: steroid cell tumor not otherwise specified (NOS), stromal luteoma and Leydig cell tumor. Steroid cell tumor, NOS, is the most common type and has malignant potential. This report describes a case of an ovarian steroid cell tumor, NOS. A 35-year-old woman visited hospital with the complaint of metrorrhagia. Physical examination revealed increased pubic hair. Transvaginal ultrasound indentified a 4.9 x 3.4 cm, well-circumscribed and solid left ovarian tumor. After laparoscopic left oophorectomy, the tumor was revealed as an ovarian steroid cell tumor, NOS. During the laparoscopic surgery, tumor ruptured. Complete surgical staging was performed and no evidence of metastasis was found. Gonadotropin releasing hormone agonist was administered monthly for 6 months. The patient has had no evidence of recurrence for 43 months.
